| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activation and disease control of patients on chronic hemodialysis: An observational study
|
Ramírez-Sánchez, Sara
|
|
|
44 |
3 |
p. 423-430
|
artikel
|
| 2 |
Association between CYP4A11 and EPHX2 genetic polymorphisms and chronic kidney disease progression in hypertensive patients
|
Suárez-Santisteban, Miguel A.
|
|
|
44 |
3 |
p. 382-395
|
artikel
|
| 3 |
Bisphenol A in renal insufficiency: how long will it be used? Is it time to avoid it?
|
González-Parra, Emilio
|
|
|
44 |
3 |
p. 313-316
|
artikel
|
| 4 |
C4d expression in focal segmental glomerulosclerosis
|
Chávez Valencia, Venice
|
|
|
44 |
3 |
p. 402-407
|
artikel
|
| 5 |
Chronic kidney disease, dialysis and climate change
|
Otero González, Alfonso
|
|
|
44 |
3 |
p. 331-337
|
artikel
|
| 6 |
Coexistence of steroid-resistant minimal change disease and familial Mediterranean fever: A case report
|
Intas, Kadir
|
|
|
44 |
3 |
p. 448-450
|
artikel
|
| 7 |
Comparison of efficacy and safety of the new generation helixone dialyzers
|
Maduell, Francisco
|
|
|
44 |
3 |
p. 354-361
|
artikel
|
| 8 |
Contrast-induced encephalopathy in patients with advanced chronic kidney disease: What the nephrologist needs to know
|
Escudero-Saiz, Víctor Joaquín
|
|
|
44 |
3 |
p. 317-322
|
artikel
|
| 9 |
Correlation of plasmatic sodium determined by the laboratory and that determined by the dialysis machine
|
Casals, Joaquim
|
|
|
44 |
3 |
p. 417-422
|
artikel
|
| 10 |
Definition and evolution of the concept of sarcopenia
|
Sanchez-Tocino, Maria Luz
|
|
|
44 |
3 |
p. 323-330
|
artikel
|
| 11 |
Earlier onset of treatment improves the nephroprotective effect of dapagliflozin
|
Gippini, Antonio
|
|
|
44 |
3 |
p. 431-433
|
artikel
|
| 12 |
Effect of a multidisciplinary team in the management of vascular access for hemodialysis
|
Leblic Ramírez, Israel
|
|
|
44 |
3 |
p. 450-452
|
artikel
|
| 13 |
Effect of early treatment with dapagliflozin on the natural history of chronic kidney disease
|
Marchán-López, Álvaro
|
|
|
44 |
3 |
p. 435-436
|
artikel
|
| 14 |
Experience with dulaglutide in a diabetic and obese patient on incremental peritoneal dialysis
|
González Sanchidrián, Silvia
|
|
|
44 |
3 |
p. 442-444
|
artikel
|
| 15 |
Hypertonic saline and heart failure: "sodium-centric" or "chlorine-centric"?
|
Mazón-Ruiz, Jaime
|
|
|
44 |
3 |
p. 338-343
|
artikel
|
| 16 |
IgA nephropathy and hematuria after getting vaccine for SARS-CoV-2
|
Daungsupawong, Hinpetch
|
|
|
44 |
3 |
p. 455-456
|
artikel
|
| 17 |
Management of refractory pruritus with difelikefalin in a patient on incremental hemodialysis one day a week: Is it safe and effective?
|
de la Flor, José C.
|
|
|
44 |
3 |
p. 437-439
|
artikel
|
| 18 |
Mesangial and endocapilar proliferative glomerulonephritis and scabies infection: A causal or circumstantial relationship?
|
González Martínez, Miguel Ángel
|
|
|
44 |
3 |
p. 446-447
|
artikel
|
| 19 |
Pre-eclampsia: An important risk factor for chronic kidney disease frequently and unfortunately forgotten
|
DaSilva Santos, Iara
|
|
|
44 |
3 |
p. 453-454
|
artikel
|
| 20 |
Preoperative mapping and multidisciplinary team are the key to success of arteriovenous access for hemodialysis
|
Fraga Dias, Bruno
|
|
|
44 |
3 |
p. 344-353
|
artikel
|
| 21 |
Randomized clinical trial of non-antibiotic prophylaxis with d-Mannose plus Proanthocyanidins vs. Proanthocyanidins alone for urinary tract infections and asymptomatic bacteriuria in de novo kidney transplant recipients: The Manotras study
|
Rau, Melissa
|
|
|
44 |
3 |
p. 408-416
|
artikel
|
| 22 |
Real-world experience with mild-moderate COVID-19 therapies in kidney transplant patients: How to treat patients with chronic kidney disease from now on?
|
Alonso, Marta
|
|
|
44 |
3 |
p. 433-435
|
artikel
|
| 23 |
Renal arterial resistive index as a prognostic marker in lupus nephritis patients
|
Abdul Hamid, Samir Kamal
|
|
|
44 |
3 |
p. 373-381
|
artikel
|
| 24 |
Response to “Experience with dulaglutide in an obese diabetic patient on incremental peritoneal dialysis”. Response to related letter
|
De La Flor, José C.
|
|
|
44 |
3 |
p. 444-446
|
artikel
|
| 25 |
Response to the attached letter “IgA nephropathy and hematuria after getting vaccine for SARS-CoV-2” by H. Daungsupawong and V. Wiwanitkit
|
Calle Garcia, Leonardo
|
|
|
44 |
3 |
p. 456-457
|
artikel
|
| 26 |
Response to the letter: “Preeclampsia: a relevant chronic kidney disease risk factor frequently and unfortunately forgotten”
|
Górriz, Jose Luis
|
|
|
44 |
3 |
p. 454-455
|
artikel
|
| 27 |
Survival and its relationship with the type of peritoneal solute transfer rate, in patients with chronic kidney disease incident on peritoneal dialysis therapy in RTS Colombia between the years 2007–2017
|
Rafael Alberto, Gómez
|
|
|
44 |
3 |
p. 362-372
|
artikel
|
| 28 |
Tixagevimab-cilgavimab como tratamiento profiláctico preexposición frente a SARS-CoV-2 en pacientes trasplantados renales
|
Bravo González-Blas, Luis
|
|
|
44 |
3 |
p. 396-401
|
artikel
|
| 29 |
Treatments and diets associated with resistant arterial hypertension and their influence on the efficacy of spironolactone
|
Quiñonez Quiñones, Nicolle Fabiola
|
|
|
44 |
3 |
p. 439-440
|
artikel
|
| 30 |
Unconventional route of administration of sodium zirconium cyclosilicate via nasogastric tube: A case report
|
Barrales Iglesias, Miriam
|
|
|
44 |
3 |
p. 440-442
|
artikel
|
Tijdschrift beschrijving